BET Inhibitors Market – Targeting Epigenetic Regulators for Cancer and Beyond
The BET (bromodomain and extra-terminal) inhibitors market is an emerging segment of the pharmaceutical industry, focused on developing drugs that target BET proteins, which play a key role in regulating gene expression by binding to acetylated histones. By inhibiting BET proteins, these drugs can modulate the expression of oncogenes and other disease-related genes, offering promising...
0 Yorumlar 0 hisse senetleri 23 Views 0 önizleme